Why the study?
How should anticoagulant and antiplatelet medications be managed in patients requiring dentoalveolar surgery?
How should anticoagulant and antiplatelet medications be managed in patients requiring dentoalveolar surgery?
This review summarizes current recommendations for managing patients on aspirin, warfarin, or clopidogrel who require dentoalveolar surgery.
Provides synthesis of perioperative recommendations for dentoalveolar surgery; leaves open need for prospective validation with newer agents.
Patients with a variety of medical conditions often receive aspirin, warfarin or clopidogrel to prevent complications from atrial fibrillation, thromboembolisms or stroke. Although these medications can be lifesaving; it also can put patients at greater risk of experiencing haemorrhage after dental surgery. Therefore, a decision must be made whether to interrupt or continue anticoagulant treatment in patients undergoing various dental procedures. We have presented a review of this topic, including a brief description of the more commonly encountered anticoagulant and antiplatelet medications and the current recommendations for the surgical management of these patients.
No takes yet. Share an insight, caveat, or question.
Galinde et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: